Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_assertion type Assertion NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_head.
- NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_assertion wasGeneratedBy ECO_0000203 NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_provenance.
- NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_assertion wasDerivedFrom befree-2016 NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_provenance.
- NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_assertion SIO_000772 21210765 NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_provenance.
- NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_assertion evidence source_evidence_literature NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_provenance.
- NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_assertion description "[Thus, the present study has identified RECQL5 as a major determinant for CPT resistance in colorectal cancer cells and a potential candidate as a biomarker for irinotecan-based treatment for colon cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP863501.RAHRUDzc0cfrXEI9RT_YoXZ9XJyXJ_1Fd0-wIjO-I8-IE130_provenance.